Whalesbook
Dr Reddy's Laboratories has secured marketing authorisation from the European Commission for its biosimilar AVT03, designed to treat osteoporosis and prevent bone complications in cancer patients. This approval covers all EU and EEA countries, paving the way for commercialisation in partnership with Alvotech.